These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28283608)

  • 1. Response by Hänggi and Macdonald to Letter Regarding Article, "Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])".
    Hänggi D; Macdonald RL
    Stroke; 2017 Apr; 48(4):e114. PubMed ID: 28283608
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Rustemi Regarding Article, "Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])".
    Rustemi O
    Stroke; 2017 Apr; 48(4):e113. PubMed ID: 28283604
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage]).
    Hänggi D; Etminan N; Aldrich F; Steiger HJ; Mayer SA; Diringer MN; Hoh BL; Mocco J; Faleck HJ; Macdonald RL;
    Stroke; 2017 Jan; 48(1):145-151. PubMed ID: 27932607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage.
    Hänggi D; Etminan N; Macdonald RL; Steiger HJ; Mayer SA; Aldrich F; Diringer MN; Hoh BL; Mocco J; Strange P; Faleck HJ; Miller M
    Neurocrit Care; 2015 Oct; 23(2):274-84. PubMed ID: 25678453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NEWTON-2 Cisternal (Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage): A Phase 2, Multicenter, Randomized, Open-Label Safety Study of Intracisternal EG-1962 in Aneurysmal Subarachnoid Hemorrhage.
    Macdonald RL; Hänggi D; Ko NU; Darsaut TE; Carlson AP; Wong GK; Etminan N; Mayer SA; Aldrich EF; Diringer MN; Ng D; Strange P; Bleck T; Grubb R; Suarez JI
    Neurosurgery; 2020 Dec; 88(1):E13-E26. PubMed ID: 32985652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)].
    Hänggi D; Etminan N; Mayer SA; Aldrich EF; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Macdonald RL;
    Neurocrit Care; 2019 Feb; 30(1):88-97. PubMed ID: 30014184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local delivery of nimodipine by prolonged-release microparticles-feasibility, effectiveness and dose-finding in experimental subarachnoid hemorrhage.
    Hänggi D; Perrin J; Eicker S; Beseoglu K; Etminan N; Kamp MA; Heiroth HJ; Bege N; Macht S; Frauenknecht K; Sommer C; Kissel T; Steiger HJ
    PLoS One; 2012; 7(9):e42597. PubMed ID: 23049732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage.
    Carlson AP; Hänggi D; Wong GK; Etminan N; Mayer SA; Aldrich F; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Bleck T; Grubb R; Miller M; Suarez JI; Proskin HM; Macdonald RL;
    Stroke; 2020 Apr; 51(4):1142-1149. PubMed ID: 32138631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracranial biodegradable silica-based nimodipine drug release implant for treating vasospasm in subarachnoid hemorrhage in an experimental healthy pig and dog model.
    Koskimäki J; Tarkia M; Ahtola-Sätilä T; Saloranta L; Simola O; Forsback AP; Laakso A; Frantzén J
    Biomed Res Int; 2015; 2015():715752. PubMed ID: 25685803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nimodipine for the prevention of cerebral vasospasm after subarachnoid hemorrhage in 12 children.
    Heffren J; McIntosh AM; Reiter PD
    Pediatr Neurol; 2015 Mar; 52(3):356-60. PubMed ID: 25585913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ forming nimodipine depot system based on microparticles for the treatment of posthemorrhagic cerebral vasospasm.
    Bege N; Renette T; Endres T; Beck-Broichsitter M; Hänggi D; Kissel T
    Eur J Pharm Biopharm; 2013 May; 84(1):99-105. PubMed ID: 23298622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Site-Specific, Sustained-Release Drug Delivery System for Aneurysmal Subarachnoid Hemorrhage.
    Hänggi D; Etminan N; Steiger HJ; Johnson M; Peet MM; Tice T; Burton K; Hudson B; Turner M; Stella A; Heshmati P; Davis C; Faleck HJ; Macdonald RL
    Neurotherapeutics; 2016 Apr; 13(2):439-49. PubMed ID: 26935204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aneurysmal Subarachnoid Hemorrhage: Strategies for Preventing Vasospasm in the Intensive Care Unit.
    Diringer MN; Zazulia AR
    Semin Respir Crit Care Med; 2017 Dec; 38(6):760-767. PubMed ID: 29262433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral vasospasm and health-related quality of life after subarachnoid hemorrhage.
    Tjahjadi M; König R; Wirtz CR; Woischneck D; Kapapa T
    World Neurosurg; 2013; 80(1-2):113-20. PubMed ID: 23022640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is intra arterial nimodipine really beneficial in vasospasm following aneurysmal subarachnoid hemorrhage?
    Kumar A; Phalak M
    Br J Neurosurg; 2017 Jun; 31(3):290. PubMed ID: 28397570
    [No Abstract]   [Full Text] [Related]  

  • 17. Intracranial drug delivery for subarachnoid hemorrhage.
    Macdonald RL; Leung M; Tice T
    Ther Deliv; 2012 Jan; 3(1):91-103. PubMed ID: 22833935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Locally Delivered Nimodipine Microparticles on Spreading Depolarization in Aneurysmal Subarachnoid Hemorrhage.
    Carlson AP; Alchbli A; Hänggi D; Macdonald RL; Shuttleworth CW
    Neurocrit Care; 2021 Feb; 34(1):345-349. PubMed ID: 32103439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
    Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
    Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage.
    Musahl C; Henkes H; Vajda Z; Coburger J; Hopf N
    Neurosurgery; 2011 Jun; 68(6):1541-7; discussion 1547. PubMed ID: 21311378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.